Quantum biopharma corporate update

Toronto, ontario--(newsfile corp. - april 18, 2025) - quantum biopharma ltd. (nasdaq: qntm) (cse: qntm) (fse: 0k91) (upstream: qntm) ("quantum biopharma" or the "company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, today announced the following corporate updates.
QNTM Ratings Summary
QNTM Quant Ranking